Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has a mean price target of $20.00 by market experts. Market leading group First Call has reached this recommendation by considering recommendations of top analysts in the industry. These experts have specified earnings of $-0.13 a share for the very next quarter and $1.02 for this year.
The technical study of Enanta Pharmaceuticals, Inc. demonstrates that the 50-day moving average of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) stock is $22.65, and is trading $1.65 points away or +7.28% from 50-day moving average of $22.65. It is trading $-0.90 or -3.55% away 200-day moving average of $25.20.
The 52-week high of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) was $43.08 while $16.75 is the low mark in the same period. It state Enanta Pharmaceuticals, Inc. share price has to surge more than $-18.78 to hit 52-week high or drop +45.07% to make a 52-week mark. MA here hints at moving average.
Taking the valuation part to reach the estimation of Enanta Pharmaceuticals, Inc., investors apply price-to-earnings ratio, which is shortened as P/E ratio. It weighs equity price by the relative expense of the equity. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) ratio came in at 16.07, after dividing current equity price by yearly earnings. Enanta Pharmaceuticals, Inc. stock recorded a close of $24.30 in last trading session, registering a market cap of $462.55M.
The price-earnings ratio can be seen as a means of regulating the value of per dollar of earnings through the stock market. In concept, by taking the average of P/E over a period of numerous years, one could frame something of a uniform P/E ratio, which can then be understood as a benchmark and utilized to indicate whether or not a share is worth buying.
Investors estimate the Price-to-Earnings-Growth ratio to catch up with a clear view on the firm valuation. For stocks with higher PEG ratio, they are considered as sell option. The undervalued equity displays PEG ratio of 0 or 1. On contrary, the fairly valued equity has ratio of 1 and 2. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) PEG ratio is at 0.00.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...